Copy number alterations detected by sequencing using the Onco-Chase-AS01 panel. (A) ERBB2 amplification in brain cancer patient and quantitative polymerase chain reaction (PCR) result of ERBB2 amplification. (B) CDKN2A copy number deletion in sarcoma cancer patient and quantitative PCR result of CDKN2A copy number deletion.